Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.
type: Distribution
access URL: https://inserm.hal.science/inserm-00815985
format: HTML
issued: 2026-05-11T09:34:52.334666
modified: 2026-05-11T09:34:52.310776

test_moissonnage_selune
type: Agent

Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.
type: Dataset
contact point: Organization
  fn: CCSD
keyword: sdvimmlife-sciences-q-bioimmunology
keyword: her3
keyword: infoinfo-btcomputer-science-csbiotechnology
keyword: signaling
keyword: infoeu-reposemanticsarticle
keyword: treatment
keyword: antibody
keyword: cancer
keyword: sdvbiolife-sciences-q-biobiotechnology
keyword: sdvcanlife-sciences-q-biocancer
keyword: journal-articles
landing page: 1522-8002
description: International audience
issued: 2026-05-11T09:34:52.331325
language: en
modified: 2026-05-11T09:34:52.331331